MPG,
Learning,
CDA,
Woman,
CAF,
Military academy,
TSX,
Partnership,
CGY,
DNA,
Nursing OTTAWA, May 07, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions has renewed a contract worth $10M to provide military training support services for the Canadian Defence Academy (CDA) and Military Personnel Generation Group (MPG).
Key Points:
- OTTAWA, May 07, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions has renewed a contract worth $10M to provide military training support services for the Canadian Defence Academy (CDA) and Military Personnel Generation Group (MPG).
- Calian will deliver comprehensive academic and developmental support, clerical support, training support, instructional support, and courseware development in relation to Canadian Armed Forces (CAF) training courses provided through the CDA and MPG.
- Work will bolster critical training programs across Canada, elevating operational readiness when the CAF cannot afford to fail.
- For more on Calian as the training partner of choice, visit Calian Defence .
Calian will deliver comprehensive administrative, instructional and courseware development solutions to enhance CFHSG training initiatives across Canada, including support for the Royal Canadian Dental Corps and Canadian Forces Medical Services.
Key Points:
- Calian will deliver comprehensive administrative, instructional and courseware development solutions to enhance CFHSG training initiatives across Canada, including support for the Royal Canadian Dental Corps and Canadian Forces Medical Services.
- “This contract signifies a milestone achievement, combining Calian’s longstanding expertise in both military training and healthcare services to fulfill critical training needs,” says Kevin Ford, CEO, Calian.
- This project further illustrates how Calian’s health and training divisions collaborate to streamline and enhance training delivery.
- For more on Calian as the training partner of choice, visit Calian Defence .
Retrieved on:
Wednesday, March 27, 2024
OTTAWA, March 27, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, is pleased to appoint Valérie Travain-Milone as President, Advanced Technologies (AT).
Key Points:
- OTTAWA, March 27, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, is pleased to appoint Valérie Travain-Milone as President, Advanced Technologies (AT).
- Known for her purpose-driven approach and passion for technology, she has consistently nurtured teams towards success and growth.
- Together, we will continue pushing the boundaries of what’s possible.”
Travain-Milone will officially join Calian on April 8th, 2024, taking over from outgoing President of AT, Patrick Thera, who is retiring after more than 40 years with Calian.
- Thera will stay on until June 3, 2024, to ensure a smooth transition for our customers, employees, partners and suppliers.
OTTAWA, March 21, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions has won a contract with the Canadian Space Agency (CSA) to develop a spectrum interference simulation solution.
Key Points:
- OTTAWA, March 21, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions has won a contract with the Canadian Space Agency (CSA) to develop a spectrum interference simulation solution.
- Calian’s spectrum interference simulation software will help the CSA coordinate frequency for the ongoing shared use of valuable Radio Frequency (RF) spectrum.
- This support will sustain the CSA's continuous missions, emphasizing current and future Earth observation endeavours.
- Calian's simulation technology will equip the CSA with vital insights, enabling efficient planning and preparation to navigate the challenges presented by heightened spectral congestion.
MDA’s nuclear team will be integrated into Calian’s existing Nuclear business within its Advanced Technologies segment.
Key Points:
- MDA’s nuclear team will be integrated into Calian’s existing Nuclear business within its Advanced Technologies segment.
- “The MDA Nuclear team will add new capabilities and services to Calian’s existing nuclear business,” says Kevin Ford, CEO, Calian.
- The addition of MDA’s nuclear team to Calian will create strong synergies, including the ability to better serve their mutual client, Bruce Power.
- Additionally, Calian Nuclear can better support operations of existing nuclear facilities and refurbishments of the existing facilities.
Retrieved on:
Tuesday, February 20, 2024
CGY,
Clinical trial,
TSX,
Pain,
Data management,
Learning,
Safety,
Contract research organization,
Chronic pain,
Patient,
Knowledge,
Medical writing,
Partnership,
Pharmaceutical industry Calian's full-service Contract Research Organization (CRO) will apply its extensive clinical trial management experience to support a Phase 2 Clinical Trial for Trichomylin softgel capsules.
Key Points:
- Calian's full-service Contract Research Organization (CRO) will apply its extensive clinical trial management experience to support a Phase 2 Clinical Trial for Trichomylin softgel capsules.
- “Calian will apply our industry-leading expertise to support this Phase 2 Clinical Trial and further ZYUS’ pursuit of transformational impact on patients’ lives,” says Derek Clark, President, Calian Health.
- Calian will provide full-service, end-to-end expertise to support this trial, including medical writing, regulatory affairs, clinical operations, site monitoring, data management, medical monitoring and quality assurance.
- By collaborating with an industry leading contract research organization with extensive experience in clinical trial management, we can leverage invaluable knowledge and expertise."
Retrieved on:
Tuesday, February 20, 2024
OTTAWA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The following matter was voted upon at the Annual Meeting of Shareholders of Calian® Group Ltd. (TSX:CGY), held on February 15, 2024 in Toronto, Ontario.
Key Points:
- OTTAWA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The following matter was voted upon at the Annual Meeting of Shareholders of Calian® Group Ltd. (TSX:CGY), held on February 15, 2024 in Toronto, Ontario.
- This and other matters voted upon are described in greater detail in the Notice of Annual Meeting of Shareholders dated December 18, 2023 and Management Proxy Circular dated December 18, 2023.
- Detailed results of the vote for the election of directors are set out below.
Retrieved on:
Wednesday, February 14, 2024
OTTAWA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, today released its results for the first quarter ended December 31, 2023.
Key Points:
- “Steps to restore our efficiency are bearing fruit with gross margin at an all-time high and adjusted EBITDA1 margin bordering on 11%.
- These results demonstrate the strength of our business model, our diversification into new markets and offerings as well as the value creation generated from our M&A agenda.
- “In the first quarter we generated $14.2 million in operating free cash flow1, representing a 73% conversion rate from adjusted EBITDA1,” said Patrick Houston, Calian CFO.
- We ended the quarter with $139 million in net liquidity, well-positioned to pursue our growth objectives,” concluded Mr. Houston.
Retrieved on:
Thursday, February 1, 2024
OTTAWA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, will hold a conference call at 8:00 a.m. Eastern Time on Thursday, February 15, 2024, to discuss results for the three-month period ended December 31, 2023.
Key Points:
- OTTAWA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, will hold a conference call at 8:00 a.m. Eastern Time on Thursday, February 15, 2024, to discuss results for the three-month period ended December 31, 2023.
- The results will be released on Wednesday, February 14, 2024, after financial markets close.
- Interested participants from the financial and media community should join the live presentation by going to the Calian website and clicking on the Investors section to find the conference call link or directly via the following URL: https://edge.media-server.com/mmc/p/ki9ocmsc
A replay of the audio webcast will be available at the same location following the conclusion of the call.
OTTAWA, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, has completed the acquisition of Decisive Group for up to CAD$74.7 million.
Key Points:
- OTTAWA, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, has completed the acquisition of Decisive Group for up to CAD$74.7 million.
- A leader in the IT infrastructure and cyber security services business, the acquisition of Decisive rounds out Calian’s North American offerings.
- It also positions the Calian IT and Cyber Solutions (ITCS) portfolio to expand further into global markets—serving a broader set of customers.
- Calian confirms that it will be filing its FY23 audited financial statements today with no changes to its previously published financial results released earlier this week.
